Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |